MB, Levis & Associates’s Cronos Group CRON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$917 Hold
330
﹤0.01% 243
2026
Q1
$828 Hold
330
﹤0.01% 221
2025
Q4
$868 Hold
330
﹤0.01% 233
2025
Q3
$917 Hold
330
﹤0.01% 232
2025
Q2
$630 Hold
330
﹤0.01% 255
2025
Q1
$597 Hold
330
﹤0.01% 267
2024
Q4
$667 Hold
330
﹤0.01% 275
2024
Q3
$723 Hold
330
﹤0.01% 274
2024
Q2
$769 Hold
330
﹤0.01% 268
2024
Q1
$861 Hold
330
﹤0.01% 262
2023
Q4
$690 Hold
330
﹤0.01% 261
2023
Q3
$660 Hold
330
﹤0.01% 264
2023
Q2
$650 Hold
330
﹤0.01% 266
2023
Q1
$640 Hold
330
﹤0.01% 264
2022
Q4
$838 Buy
+330
New +$967 ﹤0.01% 238

Other funds holding CRON

MB, Levis & Associates's CRON Position: Q2 2026 in Review

MB, Levis & Associates held its Cronos Group (CRON) position steady in Q2 2026 at 330 shares worth $917. The position accounts for ﹤0.01% of the portfolio, ranked #243.

MB, Levis & Associates first reported a position in CRON in Q4 2022 and has held it in 15 quarters since. 195 funds tracked by Wall St. Rank hold CRON as of Q2 2026.

  • MB, Levis & Associates held 330 shares of Cronos Group worth $917 as of Q2 2026.
  • MB, Levis & Associates left its Cronos Group share count unchanged in Q2 2026.
  • Cronos Group made up ﹤0.01% of MB, Levis & Associates's portfolio in Q2 2026, its #243 holding.
  • MB, Levis & Associates first reported a position in Cronos Group in Q4 2022 and has held it in 15 quarters since.
  • 195 funds tracked by Wall St. Rank held Cronos Group as of Q2 2026.

Based on MB, Levis & Associates's 13F filing for Q2 2026, filed 22 Jul 2026.